Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathalie Letarte

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 29, 2016
Safe administration of docetaxel after weekly paclitaxel-induced acute pancreatitisJean-Philippe Adam, Philippe Gauthier, Nathalie Letarte
Cancer Chemotherapy and Pharmacology|December 8, 2011
Going past the data for temozolomideJ Lee Villano, Nathalie Letarte, Linda R Bressler
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 7, 2017
Should mannitol be reinstated in prevention of cisplatin-induced nephrotoxicity?Jean-Philippe Adam, Marie-Andrée Fournier, Nathalie Letarte
Cancer Chemotherapy and Pharmacology|April 9, 2013
Bevacizumab and central nervous system (CNS) hemorrhageNathalie Letarte, Linda R Bressler, John L Villano
Gynecologic Oncology|July 29, 2017
Single agent trabectedin in heavily pretreated patients with recurrent ovarian cancerJean-Philippe Adam, Feriel Boumedien, Nathalie Letarte, et al.
Pharmacoeconomics|March 23, 2016
Use of Intermediate Endpoints in the Economic Evaluation of New Treatments for Advanced Cancer and Methods Adopted When Suitable Overall Survival Data are Not AvailableCatherine Beauchemin, Marie-Ève Lapierre, Nathalie Letarte, et al.
Cancer Chemotherapy and Pharmacology|May 27, 2011
Hematologic adverse events associated with temozolomideJ Lee Villano, Nathalie Letarte, Janny M Yu, et al.
Journal of Neuro-Oncology|July 17, 2014
Analyzing temozolomide medication errors: potentially fatalNathalie Letarte, Michael P Gabay, Linda R Bressler, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 3, 2022
Management of adverse events related to first-generation tyrosine receptor kinase inhibitors in adults: a narrative reviewChristine Martineau, Maria-Kim Turcotte, Noémie Otis, et al.
The Canadian Journal of Hospital Pharmacy|July 6, 2023
Impact of Pharmacist-Provided Education Using New Information Sheets on Activation in Patients Treated with Oral Antineoplastic Drugs (IMPACT-OAD Project)Karine Almanric, Viviane Le-Nguyen, Sandrine Léger, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 29, 2016
Safe administration of docetaxel after weekly paclitaxel-induced acute pancreatitisJean-Philippe Adam, Philippe Gauthier, Nathalie Letarte
Cancer Chemotherapy and Pharmacology|December 8, 2011
Going past the data for temozolomideJ Lee Villano, Nathalie Letarte, Linda R Bressler
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 7, 2017
Should mannitol be reinstated in prevention of cisplatin-induced nephrotoxicity?Jean-Philippe Adam, Marie-Andrée Fournier, Nathalie Letarte
Cancer Chemotherapy and Pharmacology|April 9, 2013
Bevacizumab and central nervous system (CNS) hemorrhageNathalie Letarte, Linda R Bressler, John L Villano
Gynecologic Oncology|July 29, 2017
Single agent trabectedin in heavily pretreated patients with recurrent ovarian cancerJean-Philippe Adam, Feriel Boumedien, Nathalie Letarte, et al.
Pharmacoeconomics|March 23, 2016
Use of Intermediate Endpoints in the Economic Evaluation of New Treatments for Advanced Cancer and Methods Adopted When Suitable Overall Survival Data are Not AvailableCatherine Beauchemin, Marie-Ève Lapierre, Nathalie Letarte, et al.
Cancer Chemotherapy and Pharmacology|May 27, 2011
Hematologic adverse events associated with temozolomideJ Lee Villano, Nathalie Letarte, Janny M Yu, et al.
Journal of Neuro-Oncology|July 17, 2014
Analyzing temozolomide medication errors: potentially fatalNathalie Letarte, Michael P Gabay, Linda R Bressler, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 3, 2022
Management of adverse events related to first-generation tyrosine receptor kinase inhibitors in adults: a narrative reviewChristine Martineau, Maria-Kim Turcotte, Noémie Otis, et al.
The Canadian Journal of Hospital Pharmacy|July 6, 2023
Impact of Pharmacist-Provided Education Using New Information Sheets on Activation in Patients Treated with Oral Antineoplastic Drugs (IMPACT-OAD Project)Karine Almanric, Viviane Le-Nguyen, Sandrine Léger, et al.
Pageof 2